Filing Details
- Accession Number:
- 0001140361-15-035596
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-21 16:47:45
- Reporting Period:
- 2015-09-17
- Filing Date:
- 2015-09-21
- Accepted Time:
- 2015-09-21 16:47:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1444380 | Nevro Corp | NVRO | Surgical & Medical Instruments & Apparatus (3841) | 562568057 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1622608 | Andre Walker | C/O Nevro Corp. 4040 Campbell Avenue Menlo Park CA 94025 | Senior Vp,Research&Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-09-17 | 4,000 | $0.96 | 4,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-09-17 | 1,000 | $48.00 | 3,000 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-09-17 | 1,000 | $50.00 | 2,000 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-09-17 | 1,000 | $52.00 | 1,000 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-09-17 | 1,000 | $53.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2015-09-17 | 4,000 | $0.00 | 4,000 | $0.96 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
11,302 | 2017-12-12 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 28, 2015.
- 100% of the shares subject to the option are fully vested and exercisable.